According to eFFECTOR Therapeutics's latest financial reports the company's current EPS (TTM) is -11,24ย โฌ. In 2023 the company made an earnings per share (EPS) of -14,54ย โฌ a decrease over its 2022 EPS that were of -11,60ย โฌ.